RIO DE JANEIRO, BRAZIL - Pfizer on Wednesday, January 5, confirmed that vaccine doses against Covid-19 for children aged 5 to 11 will begin to be delivered in the week of January 10.
In a statement, the pharmaceutical company says that 20 million doses will be delivered in the first quarter this year.
According to Pfizer, the vaccine has proven 90.7% efficacy in a clinical trial designed specifically for the pediatric age group, aged 5 to 11.
Phase 2 and 3 trials were conducted in 2,268 children in the United States, Finland, Poland and Spain, and showed robust . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here